Quarterly disclosures of hedge fund managers' stock holdings, in what are known …
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor …
(RTTNews.com) - ACADIA Pharmaceuticals Inc. ( ACAD) reported a second quarter loss of $0.55 per ... open sharply higher Wednesday morning and is now up 3.88 at $33.42. The stock has jumped to a 3-month high.
They now have a USD 47 price target on the stock. The share price of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) …
Following the completion of the transaction, the executive vice president now owns 109,253 shares of the company's stock, valued at approximately $3,277,590. A number of institutional investors have recently modified their holdings of ACAD. …
It was a volatile week for shareholders in Acadia Pharmaceuticals (ACAD). The high beta parts of the market under pressure this week with the Russell 2000 dropping three percent. The company also reported earnings which caused …
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) reported its second-quarter …
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) is scheduled to report after the ... Although the current rank increases the predictive power of ESP, its 0.00% ESP makes it unlikely for the stock to beat estimates this quarter. You can …
ACADIA Pharmaceuticals Inc. (ACAD), a a biopharmaceutical company yesterday reported their second quarter 2017 financial results. The company reported second quarter earnings of a loss of $0.55 per share which fell beat analyst …
ACHN closed Tuesday's trading at $4.01, up 1.01%. In after-hours, the stock was up 27.68% to $5.12. ACADIA Pharmaceuticals Inc. ( ACAD) reported a narrower loss for the second quarter of 2017 on higher net product sales. For …